MedTrace Logo

Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases

NCT01677728 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2012-09-03

No results posted yet for this study

Summary

The aim of this study is to explore whether target therapy in combination with chemotherapy as treatment could improve survival or tumor response in patients undergoing Synchronic Hepatectomy for Colorectal Liver Metastases.

Conditions

Sponsors & Collaborators

  • Fudan University

    collaborator OTHER

  • Xu jianmin

    lead OTHER

Principal Investigators

  • Xu Jianmin, MD · Shanghai Zhongshan Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2013-12-31
Completion
2014-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01677728 on ClinicalTrials.gov